E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/6/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

Genta plans direct placement of stock

By Sheri Kasprzak

New York, March 6 - Genta Inc. said it intends to close a direct placement of stock.

The pricing terms of the deal have not yet been determined, but the company plans to sell 19 million shares.

Cowen & Co., LLC is the bookrunner for the offering and Rodman & Renshaw, LLC is a placement agent.

Based in Berkeley Heights, N.J., Genta is a biopharmaceutical company focused on treatments for cancer.

The company's stock fell $0.17 Monday to close at $2.43, but gained another $0.02 in after-hours trading (Nasdaq: GNTA).


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.